Albemarle Corporation schluckt Rockwood Holdings (Seite 21)

[stereo-typ]

-6.45% heute bisher - gibt es hier besondere Nachrichten oder geht es "nur" um die Ankuendigung von SQM, ihre Lithium-Produktion verdreifachen zu wollen?

[faultcode]

Albemarle completes sale of portion of Performance Catalysts Solutions to W. R. Grace & Co.

hier's auch noch Cash reingekommen:

April 3, 2018
https://www.gurufocus.com/news/660445/albemarle-completes-sa…

Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, announced today the successful completion of the previously announced sale of its polyolefin catalysts and components business to W. R. Grace & Co. (NYSE: GRA) in a cash transaction valued at approximately $416 million.

The proceeds are subject to typical post-closing adjustments. The organometallics and curatives portions of the Performance Catalysts Solutions business remain with Albemarle...

[coolrunning]

Earnings Highlights and Summary

Albemarle reported net sales of $857.8 million in Q4 2017, up 23.1% from net sales of $696.7 million in Q4 2016, driven by the favorable impact of higher sales volumes and pricing impacts across each of the Company's reportable segments and favorable currency exchange impacts. The Company's reported numbers beat analysts' estimates of $791.5 million.

For Q4 2017, Albemarle's net loss from continuing operations was $207.1 million, or $1.95 per diluted share, compared to $50.3 million, or $0.37 per diluted share, in Q4 2016. The Company's reported quarter results included an impact of $3.27 per diluted share of a net negative impact from the US tax reform enacted in December 2017 as well as a charge from hurricane Harvey by $0.02 per diluted share, partially offset by earnings growth in each of Albemarle's reportable segments and an increase in mark-to-market actuarial gains of $0.23 per diluted share,

For Q4 2017, Albemarle's adjusted net income from continuing operations was $149.8 million, or $1.34 per diluted share, compared to $88.8 million, or $0.78 per diluted share, for Q4 2016. The Company's earnings beat Wall Street's estimates of $1.21 per share.

Albemarle reported net sales for the full year 2017 of $3.07 billion, up 14.7% from the net sales of $2.68 billion in FY16.

For FY17, Albemarle reported net income from continuing operations of $99.5 million, or $0.49 per diluted share, compared to $478.6 million, or $3.90 per diluted share, for FY16. On an adjusted basis, the Company reported earnings of $515.9 million, or $4.59 per diluted share, compared to $403.8 million, or $3.57 per diluted share, for FY16.

Albemarle's Segment Results

During Q4 2017, the Lithium and Advanced Materials segment's net sales surged 30.2% to $362.4 million from net sales of $278.3 million in Q4 2016, primarily due to favorable pricing impacts, increased sales volumes and $3.1 million of favorable currency exchange impacts. Adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) for Lithium and Advanced Materials was $135.7 million in the reported quarter, an increase of 32.4% from the prior year's comparable quarter, primarily driven by favorable pricing impacts, increased sales volumes, and favorable currency exchange impacts.

For Q4 2017, the Bromine Specialties segment reported net sales of $219.1 million, reflecting an increase of 12.6% from net sales of $194.5 million in Q4 2016, driven by increased sales volumes and favorable pricing impacts. Adjusted EBITDA for Bromine Specialties was $64.4 million for the reported quarter, representing growth of 37.2% from adjusted EBITDA of $46.9 million in the prior year's corresponding quarter, attributed to higher volume and favorable pricing impacts.

The Refining Solutions segment reported net sales of $238.4 million in Q4 2017, up 23.5% compared to net sales of $193.1 million in Q4 2016, driven by higher sales volumes, favorable pricing impacts, and $4.3 million of favorable currency exchange impacts. The segment's adjusted EBITDA for the reported quarter was $69.2 million, up 20.7% compared to $57.3 million in the prior year's same quarter, attributed to increased volume and pricing.

Cash Matters

Albemarle's cash from operations was approximately $304.0 million for FY17, down $431.5 million versus FY16 primarily due to changes in working capital, including the payment of approximately $257 million in taxes related to the sale of the Chemetall Surface Treatment business in 2017 and the build-up of inventory in the Company's Lithium business.

As of December 31, 2017, Albemarle had $1.14 billion in cash and cash equivalents compared to $2.27 billion at December 31, 2016. During FY17, the Company's cash on hand, cash provided by operations, and net borrowings funded $778.2 million of debt repayments, primarily related to the senior notes, $317.7 million of capital expenditures for plant, machinery and equipment, dividends to shareholders of $140.6 million and a $250.0 million accelerated share repurchase program.

Outlook

For FY18, Albemarle is forecasting net sales in the range of $3.2 billion and $3.4 billion, with adjusted EBITDA between $955 million and $1.01 billion, and adjusted diluted earnings per share between $5.00 and $5.40.

http://www.finanznachrichten.de/nachrichten-2018-04/43486340…


running

[stereo-typ]

Die Morgan Stanley Analyse mit dem Kursziel $90 hat Recht behalten - aktuell stehen wir bei ca $91 und der Tag ist noch lang...

[coolrunning]

FOLGENDE WERTPAPIERE WERDEN AM 13.03.2018 CUM DIVIDENDE/ZINSEN UND AM 14.03.2018 EX DIVIDENDE/ZINSEN GEHANDELT.

INSTR EXCH ISIN INSTRUMENT NAME REF.PRC ADJUST
WXC XFRA US4617301035 INVESTORS R.ESTATE TR.SBI 0.057 EUR
HTR XFRA US4470111075 HUNTSMAN CORP. DL-,01 0.132 EUR
4W8 XFRA US3886891015 GRAPHIC PACK.HLDG DL-,01 0.061 EUR
FG8 XFRA US30225T1025 EXTRA SPACE ST.SBI DL-,01 0.635 EUR
EP7 XFRA US30049A1079 EVOLUTION PETROL. DL-,001 0.081 EUR
EAC XFRA US2774321002 EASTMAN CHEM. CO. DL-,01 0.456 EUR
EZV XFRA US25754A2015 DOMINOS PIZZA INC. DL-,01 0.447 EUR
CH5 XFRA US1653031088 CHESAPEAKE UTIL. DL-,4867 0.264 EUR
5B9 XFRA US11133T1034 BROADRIDGE FINL SOL.DL-01 0.297 EUR
QCTA XFRA US0774541066 BELDEN INC. DL -,01 0.041 EUR
9A2 XFRA US04010L1035 ARES CAPITAL CORP. 0.309 EUR
AINN XFRA US0268747849 AMER.INTL GRP NEW DL 2,50 0.260 EUR
PHM7 XFRA US02209S1033 ALTRIA GRP INC. DL-,333 0.569 EUR
AMC XFRA US0126531013 ALBEMARLE CORP. DL-,01 0.273 EUR

Die Quartalsdividende ist wieder fällig


running

[coolrunning]

https://www.sec.gov/Archives/edgar/data/915913/0000915913180…

running

[price-of-success]

Jetzt scheint ein guter Zeitpunkt zu sein.zum einstieg
Dyor

[Pebbles]

Durchaus eine bedeutende Erweiterung der Produktion

Chile's government approves an increase in Albemarle’s (NYSE:ALB) annual lithium production limit in the salt flats of the Salar de Atacama, freeing the company to take advantage of rising prices for the the metal.

The increase, authorized by Chilean development agency Corfo, will allow ALB to produce as much as 140K metric tons/year of lithium, up from 60K-80K tons/year.

In its request for an increase, ALB cited technological advancements it said would allow it to obtain more of lithium without needing to extract more brine.

ALB closed +2.5% in today's trade.

Siehe auch:

https://seekingalpha.com/news/3338125-chile-oks-increase-lit…

[Pebbles]

Rechtzeitig eingestiegen?

Oder ist es nur eine kurze Gegenbewegung nach oben?

Siehe dazu:

Getrieben vom Boom bei erneuerbaren Energien und vom Vormarsch der Elektromobilität wird es laut der Deutschen Rohstoffagentur (Dera) allein bei Lithium zu einer Vervierfachung des weltweiten Bedarfs bis 2035 kommen. Bei schweren Seltenen Erden wie Dysprosium und Terbium dürfte sich die Nachfrage verdreifachen. Die heimische Wirtschaft ist bei bestimmten Stoffen künftig aber nicht nur mit Knappheiten konfrontiert, sondern auch mit einer Konzentration auf wenige Anbieter. Etwa 60 Prozent der weltweiten Fördermenge von Palladium entfallen beispielsweise auf nur zwei Unternehmen. Und bei Lithium teilen sich laut Dera fünf Firmen den Abbaumarkt zu 90 Prozent untereinander auf.

Ausschnitt aus dem Handelsblatt:

http://www.handelsblatt.com/my/unternehmen/energie/eisenerz-…

[Pebbles]

Die Aktie hat ja nun recht stark korrigiert.

Sie ist ja auch ganz schön gestiegen in den letzten Jahren. Aber Lithium wird wohl noch weit stärker benötigt werden als in den letzten Jahren --- insofern kann ich mir hier noch höhere Kurse vorstellen als vor der Korrektur. Ich bin heute mal mit einer kleinen Position eingestiegen (auch nachdem ich die neueste Ausgabe der Actienbörse gelesen habe, die mir den Anstoß gab)